tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CORT Stock Latest News

Corcept Therapeutics’ MOMENTUM Study: Assessing Hypercortisolism in Resistant Hypertension
Company AnnouncementsCorcept Therapeutics’ MOMENTUM Study: Assessing Hypercortisolism in Resistant Hypertension
1d ago
CORT
Corcept Therapeutics Advances in Ovarian Cancer Treatment with New Phase 2 Study
PremiumCompany Announcements
Corcept Therapeutics Advances in Ovarian Cancer Treatment with New Phase 2 Study
1d ago
CORT
Corcept Therapeutics’ Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
Corcept Therapeutics’ Earnings Call: Growth Amid Challenges
7d ago
CORT
Corcept Therapeutics price target lowered to $121 from $131 at Piper Sandler
PremiumThe Fly
Corcept Therapeutics price target lowered to $121 from $131 at Piper Sandler
8d ago
CORT
Corcept Therapeutics price target lowered to $137 from $142 at Canaccord
PremiumThe Fly
Corcept Therapeutics price target lowered to $137 from $142 at Canaccord
8d ago
CORT
Corcept Therapeutics: Buy Rating Backed by Strategic Growth Initiatives and Promising Product Launches
PremiumRatingsCorcept Therapeutics: Buy Rating Backed by Strategic Growth Initiatives and Promising Product Launches
8d ago
CORT
Corcept Therapeutics Reports Revenue Growth Amid Rising Expenses
Premium
Company Announcements
Corcept Therapeutics Reports Revenue Growth Amid Rising Expenses
8d ago
CORT
Corcept Therapeutics reports Q2 EPS 29c, consensus 19c
Premium
The Fly
Corcept Therapeutics reports Q2 EPS 29c, consensus 19c
8d ago
CORT
Corcept Therapeutics Reports Q2 2025 Financial Results
PremiumCompany Announcements
Corcept Therapeutics Reports Q2 2025 Financial Results
8d ago
8K
CORT
Corcept Therapeutics Advances Long-Term Safety Study of Relacorilant for Cushing Syndrome
PremiumCompany Announcements
Corcept Therapeutics Advances Long-Term Safety Study of Relacorilant for Cushing Syndrome
9d ago
CORT
Is CORT a Buy, Before Earnings?
PremiumPre-Earnings
Is CORT a Buy, Before Earnings?
11d ago
CORT
Corcept Therapeutics’ MOMENTUM Study: A Closer Look at Hypercortisolism in Resistant Hypertension
PremiumCompany Announcements
Corcept Therapeutics’ MOMENTUM Study: A Closer Look at Hypercortisolism in Resistant Hypertension
11d ago
CORT
Corcept Therapeutics’ ALS Study: A Potential Game-Changer?
PremiumCompany AnnouncementsCorcept Therapeutics’ ALS Study: A Potential Game-Changer?
14d ago
CORT
Corcept Therapeutics Submits New Drug Application to FDA
Premium
Company Announcements
Corcept Therapeutics Submits New Drug Application to FDA
25d ago
8K
CORT
Piper Sandler pharmaceuticals analyst holds analyst/industry conference call
Premium
The Fly
Piper Sandler pharmaceuticals analyst holds analyst/industry conference call
1M ago
CORT
Corcept Therapeutics’ MOMENTUM Study: A Closer Look at Hypercortisolism in Resistant Hypertension
PremiumCompany Announcements
Corcept Therapeutics’ MOMENTUM Study: A Closer Look at Hypercortisolism in Resistant Hypertension
1M ago
CORT
Corcept Therapeutics Completes Key Study on Drug Interaction
PremiumCompany Announcements
Corcept Therapeutics Completes Key Study on Drug Interaction
1M ago
CORT
Corcept Therapeutics Explores Hypercortisolism in Hypertension: A Market Game Changer?
PremiumCompany Announcements
Corcept Therapeutics Explores Hypercortisolism in Hypertension: A Market Game Changer?
1M ago
CORT
Corcept Therapeutics’ Phase 2 Study Update: New Hope for Ovarian Cancer Treatment
PremiumCompany Announcements
Corcept Therapeutics’ Phase 2 Study Update: New Hope for Ovarian Cancer Treatment
1M ago
CORT
Corcept Therapeutics’ MOMENTUM Study: A Closer Look at Resistant Hypertension
PremiumCompany AnnouncementsCorcept Therapeutics’ MOMENTUM Study: A Closer Look at Resistant Hypertension
1M ago
CORT
Corcept Therapeutics’ Promising Phase 2 Study in Ovarian Cancer
Premium
Company Announcements
Corcept Therapeutics’ Promising Phase 2 Study in Ovarian Cancer
2M ago
CORT
Corcept says Catalyst trial met primary endpoint
Premium
The Fly
Corcept says Catalyst trial met primary endpoint
2M ago
CORT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >